Shingles Vaccine Recap: A Shingrix Primer for Primary Care
Herpes zoster vaccination rates in the US have ticked up only minimally since FDA approval of Shingrix. Brush up on the basics of the vaccine and pass it on to your patients.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 10, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
CDC: Suicidal Thoughts, Behaviors in US Adults Vary by Sociodemographic and Geographic Factors
Suicidal thoughts and behaviors among US adults arise due to several factors, including geography, socioeconomic status, and race and ethnicity, according to new CDC report.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 7, 2022
Digital Health, Remote Monitoring Technology Showcased at 2022 Consumer Electronics Show
Digital health products and advanced remote monitoring applications received more attention than ever at CES, driven by rapid evolution in the space during the COVID-19 pandemic.
Atopic Disease, Particularly Asthma, Linked to Decreased Risk of COVID-19 Infection in UK Adults
Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.
The Obesity Drug Pipeline: 10 Questions on Rx Development
Take this quick quiz to test your knowledge of recent advances most likely to have an impact on weight management in your practice.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 6, 2022
Certain Cardiovascular Conditions, Risks May be Worse for Cognition in Middle-aged Women
A Mayo Clinic study found certain cardiovascular conditions and risk factors are more strongly associated with cognitive decline in middle-aged women than men.
Platelet-rich Plasma Injections for Osteoarthritis: How Effective Are They?
Platelet-rich plasma, in theory, seems like a logical and potentially beneficial treatment for osteoarthritis. Our pain expert reviews 2 recent studies that are telling.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 5, 2022
AAP Recommends Routine HIV Screening for all Adolescents Starting at Age 15
The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.
Pandemic-induced Sleep Disturbance Affects More than Half of US Adults
"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.
New Study Suggests Obesity is Modifiable Risk Factor for Severe COVID-19 Infection
Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 4, 2022
American Diabetes Association Publishes Standards of Medical Care for 2022
The ADA's annual update to its comprehensive evidence-based standards includes new guidance on diabetes screening, first-line therapies, and comorbid NAFLD/NASH.
J&J Booster Found 85% Effective Against Severe Disease During Peak Omicron Case Load
The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 3, 2022
FDA Authorizes Use of Pfizer COVID-19 Vaccine Booster Dose in Children Aged 12 to 15 Years
Pending endorsement from the CDC, adolescents can now get a booster dose of the Pfizer-BioNTech vaccine, as authorized by an amendment to the original FDA EUA for the vaccine.
FDA approves HIV pre-exposure preventive injection
Cabotegravir extended-release injectable suspension is the first injectable PrEP to receive FDA approval and is given only every 2 months.
